Navigation Links
Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway
Date:7/8/2009

LA JOLLA, Calif., and BARCELONA, July 8 /PRNewswire/ -- Fate Therapeutics, Inc. announced today the presentation of data from its research on small molecule modulators of the Wnt pathway for osteo-regeneration at the 7th Annual Meeting of the International Society for Stem Cell Research (ISSCR) in Barcelona, Spain. In its findings, the Company demonstrated that selected Wnt activators induce the differentiation of mesenchymal stem cells to mature, bone-forming osteoblasts. The study highlights the potential for using small molecule Wnt activators as osteogenic agents. Because osteogenic agents stimulate positive bone growth, they may offer an improved course of action in clinical settings ranging from orthopedics to osteoporosis as compared to current medications aimed at preventing bone decay.

"By applying our knowledge of adult stem cell biology to mesenchymal stem cell populations, we have identified osteogenic small molecules that can direct lineage-specific differentiation to an osteoblast phenotype," said Paul Grayson, president and CEO of Fate Therapeutics. "While current therapies focus on blocking bone degeneration, novel small molecules that promote bone formation represent the next-generation of therapeutic agents for osteo-regenerative medicine."

Fate Therapeutics is utilizing its adult stem cell biology engine and induced pluripotent stem cell (iPSC) technology platform to develop Stem Cell Modulators (SCMs) - small molecules and biologics that guide cell fate for therapeutic purposes. Naturally-occurring adult stem cells, such as mesenchymal stem cells, can differentiate into a variety of cell types and are found in almost all tissues or organs in the body where they are primarily responsible for maintaining and repairing their native tissue. The ability of SCMs to promote bone regeneration may be applied to treat a number of bone injuries
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Elegance for a woman takes on ... her taste, her intrigue can often be found in the mystery ... a woman's soul is through her eyes. It is also ... is! That is why the elegance of a woman can be ... Women today, more than any other time, utilize eyewear to not ...
(Date:5/23/2013)... 2013 Aero Fulfillment Services, a national ... NewWave Biosciences to be the sole fulfillment provider for ... , Brad Cole, CEO New Wave Biosciences said, ... their central location, e-commerce experience with both of our ... end-to-end solution that will expand as our distribution grows.” ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Each month ... most innovative and stylish eco-friendly hybrids and electric cars. Nowhere ... in Los Angeles, the symbolic green car capital. Thankfully this ... Car Tour ride and drive back to Dwell on ... event. , During the first two days of Dwell ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Maintaining ... today launches its Summer Health Campaign. Kicking off in ... to offering a luxury bed for everyone and to ... overall health and well-being. , May is Better Sleep ... by the Better Sleep Council due to the Centers ...
(Date:5/23/2013)... two-thirds of patients with high-risk neuroblastoma a common tumor ... cured using tumor-killing cancer drugs. A study published by ... Chemistry & Biology reveals a new genomic approach ... by causing cancer cells to differentiate, or convert from ... screening method, the researchers identified a compound that causes ...
Breaking Medicine News(10 mins):Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2
... Jan. 8 A proposal by the State of ... Home has prompted the 125,000-member American Legion Department of ... 2009, in order to organize and coordinate its members, ... provides more than $50,000 in direct and in-kind support ...
... Jan. 8 United Jewish Communities (UJC) and the ... $10 million to address humanitarian and social needs in ... and stand in solidarity with Israelis during the current ... the Gaza Strip. The funds will enhance programs supported ...
... in French . -->, ... McGill University Health Centre (RI MUHC) and the McGill University ... Canadian and Belgian institutions, have discovered DNA variations in a ... was published in the January issue of the journal ...
... Nassau ColiseumNEW YORK, Jan. 8 Stand Up for a ... -- a Valentine,s Day show with Barry Manilow , in ... be held on February 14th, 2009 at Nassau Coliseum, and tickets ... Ticketmaster.com or by calling Stand Up for a Cure at 212 ...
... Many companies are starting out,the new year with ... than,ever will your success be dependent on your ... To excel in 2009 and win customers, hearts ... customer,listening posts, optimizing complaint management, applying savvy market,segmentation, ...
... We hear it everywhere: "What is your carbon footprint?" ... and how can you reduce yours? It isn,t all ... and planning to bring it down.Listen to this report from ... journalists can access video, audio, text, graphics and photos for ...
Cached Medicine News:Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 2Health News:McGill researchers discover gene that increases susceptibility to Crohn's disease 3Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2
(Date:5/23/2013)...  Omeros Corporation (NASDAQ: OMER ) ... (IND) to evaluate OMS824 in Huntington,s disease has ... Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), ... linked to a wide range of diseases that ... has shown promising results in animal models directly ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation (NASDAQ: ... be presenting at the Jefferies Healthcare Conference in New ... President and Chief Financial Officer, will be making a ... p.m. ET on Monday, June 3, 2013. A ... the "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today ... 23rd Annual Growth Stock Conference on Monday, March 14, 2011 ... in Dana Point, California and at the Barclays Capital 2011 ... a.m. ET at the Loews Miami Hotel, Florida. ...
... Inc. (Nasdaq: JAZZ ) today announced financial results for ... Total revenues for the fourth quarter of 2010 were ... 2009.  Full year 2010 revenues were $173.8 million, up 35 percent ... GAAP net income for the fourth quarter of 2010 was $24.5 ...
Cached Medicine Technology:Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 2Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 3Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 4Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 5Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 6Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 7Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results 8
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: